Since its introduction in 1967, aortocoronary bypass surgery has become a standard and accepted form of treatment for selected patients with coronary artery disease. Experience with this operation at the London Chest Hospital dates from 1970 (Ba1con et al. 1974 , Donaldson et al. 1978 and it is appropriate now to assess its place in the management of coronary disease in the light of our own observations and those of many others, particularly in the United States, comprehensively reviewed by Hurst et al. (1978) and by McIntosh & Garcia (1978) .
It is now established beyond doubt that aortocoronary bypass effectivelyrelievesangina in at least three-quarters of selected patients in whom symptoms are inadequately controlled by optimal medical treatment, including a beta-adrenergic blocking drug in maximum tolerated dose and proper use of sublingual trinitrin or isosorbide dinitrate prophylactically as well as for pain. The effect of operation on survival remains controversial; it is nevertheless agreed that in certain groups of patients, notably those with left main stem stenosis, expectation of life is improved by operation. Many believe that prognosis is improved by operation in patients with severe proximal stenoses of two or three major coronary arteries (European Coronary Surgery Study Group 1980) . In this context, it is important to note that the severity of symptoms does not necessarily reflect the severity of the disease; patients with mild angina and indeed those with no present symptoms may have advanced triple coronary artery disease.
Coronary arteriography with left ventriculography is an essential preoperative investigationto confirm the clinical diagnosis, to establish the extent and severity of the coronary arterial disease, and to assess left ventricular function. Only with this information can the cardiologist and surgeon determine the need for and the feasibility of operation, and plan the surgical procedure. Other investigations such as exercise testing and myocardial perfusion scintigraphy or radio nuclide ventriculography are useful as screening procedures but cannot replace coronary arteriography. It follows that all patients who have continuing angina despite medical treatment should have a coronary arteriogram: this includes not only those with disabling symptoms but all those in whom angina limits physical capacity 0141-0768/81/040237-04/$01.00/0 during desired working and leisure activity. Only those in whom age or infirmity or associated disease (which may shorten life or increase surgical risk) precludes operation should be excluded. Age itself is not a bar -many septuagenarians have had a successful and worthwhile bypass graft operation -but operation and therefore investigation should perhaps be offered only to those older patients whose disability is more severe and who themselves express a positive wish to consider surgical treatment.
'Unstable angina' is a strong indication for investigation. This term embraces a variety of clinical situations, including prolonged rest pain without ECG or enzyme evidence of infarction ('acute coronary insufficiency'), recurrent pain at rest or on minimal exertion, the recent onset of typical effort angina, and the sudden or gradual worsening of previously stable or recent onset angina ('crescendo angina'). Unstable angina should be managed with rest, beta-adrenergic blocking drugs, and nitrites -oral, sublingual, percutaneous (Nitro Ijelly) -and frequently settles on this treatment. The term 'pre-infarction angina' may be used because some patients with unstable angina proceed to frank infarction and/or sudden death within days or weeks of the onset; the frequency of this occurrence in patients with unstable angina depends on the precise definition of this term, but is greatest in those patients with rest pain whose symptoms do not settle. In such patients and in those in whom angina recurs when activity is resumed, investigation is clearly indicated, and many would advocate coronary arteriography in all patients with unstable angina (Brooks et al. 1981) .
Investigation is indicated in those patients who have continuing angina after infarction. This may reflect significant disease in an artery other than that which supplied the now infarcted myocardium. It may also occur when there has been infarction in the territory of a vessel critically stenosed but not completely occluded, or after complete occlusion when myocardium supplied by the blocked vessel is perfused by collaterals, particularly when the collaterals arise from a 'vessel which is itself stenosed; in these circumstances infarction may have been limited in extent and non-transmural, with T wave changes but no Q waves.
Because severe disease may be present in patients with minimal or no symptoms, a case can be made for investigating those who are asymptomatic after documented infarction and those with non-limiting stable angina, particularly those who are still relatively young. Many patients have to be investigated because of atypical chest pain, not definitely cardiac in origin, in order to make a firm diagnosis; coronary arteriography may, however, be avoided in such cases by the use of myocardial scintigraphy after exercise.
Operation is advised for one or both of two reasons. The first is the relief of angina and the second the prolongation of life. In the patient with limiting angina, operation can be expected to abolish or substantially improve symptoms, if coronary arteriograms show proximal stenosis or occlusion in one or more arteries and a graftable vessel beyond the block, whether this fills anterogradely or by ipsilateral or contralateral collaterals. Diffuse disease and/or multiple stenoses, particularly when distal vessels are involved, are unfavourable features, though sometimes an artery can be rendered graftable beyond a proximal lesion if the distal vessel can be endarterectomized. Diffuse and distal disease is commonly seen in patients with diabetes or hyperlipidaemia. Operation may be offered in such cases when angina is severe even though the prospect of obtaining complete relief of symptoms may not be good. Severe impairment of left ventricular function, as shown on the left ventriculogram or by high left ventricular enddiastolic pressure, increases the surgical risk and reduces the prospects of long-term survival in this group compared with those with normal function, but does not preclude a good result in terms of relief of angina; recent evidence suggests that operation may indeed improve prognosis.
In a condition such as coronary heart disease, in which patients may survive many years without treatment, it is difficult to establish that the chance of survival is improved by surgical treatment until many years (at least 5) have elapsed, unless the effect is a large one. It has been shown that survival of medically-treated patients depends greatly on the extent of the coronary arterial disease and on the degree of regional or general impairment of myocardial function. It is necessary, therefore, to compare survival in surgically-treated patients with that in a similar group of untreated subjects in order to establish a beneficial effect of surgery.
Problems arise when prospective randomized studies are attempted: (I) Surgical treatment which is known to relieve symptoms cannot now be withheld from symptomatic patients. Study groups must therefore consist of patients whose symptoms are mild and in whom prognosis is likely to be better. Small differences in survival may not become apparent until many years have elapsed, and in the early years may be obscured by operative mortality even when this is very low. (2) In order to obtain a large enough series, patients have to be collected from many participating centres and over a period of years. Surgical skills vary widely and in anyone institution improving surgical technique and increasing experience during the study period may invalidate the results. If the results of surgical treatment are to be evaluated, this should be the best available. (3) A substantial number of patients crossing over from medical to surgical treatment will make interpretation of results' difficult. The American Veterans Administration (VA) Cooperative Study (Murphy et al. 1977) is the best known and most widely quoted, but can be criticized on these grounds. Thus, for example, the surgical mortality and perioperative myocardial infarction rate are higher than in many series and the graft patency rate lower, suggesting a lower level of surgical expertise than in the best centres.
Alternatively, survival after operation in defined groups of surgically-treated patients can be compared with the survival of groups of closely matched patients studied after the introduction of . coronary arteriography but before coronary bypass surgery was widely used. It can be objected that during the intervening period, medical treatment has also improved and that comparison between the results of surgical treatment in the 1970s and medical treatment in the 1960s is invalid.
Despite these reservations about available data relating to survival, it seems justifiable to draw certain conclusions. It is now generally agreed that survival is improved in patients with left main stem coronary artery disease; this is the one firm conclusion of the VA trial in which the 3-year survival was 88% in the surgical group and 61% in the medical group. In many other large series, survival rates after operation are greatly superior to those observed in large nonsurgical series published earlier. Though some authors dispute the evidence, it is also becoming clear that longterm survival is improved in patients with surgically-treated triple vessel disease and double vessel disease, when results from the best centres with the lowest operative mortality are compared with data derived from presurgical series (and indeed with data from medically-treated patients in the VA trial). It also seems likely that survival is improved by operation in patients with proximal disease of the left anterior descending artery, though not in patients with isolated disease of the circumflex or right coronary artery. Operation can, however, only be justified in these patients if it can be done with an operative mortality of 1% or less. Furthermore, a distinction must be drawn between a symptomatic patient with a severe proximal stenosis of the left anterior descending artery and no demonstrated collaterals, and a symptomless patient who has survived occlusion and has good collaterals to the distal segment of the vessel.
A reasonable policy in 1981 would be to advise aortocoronary bypass surgery to patients who have limiting stable angina or continuing unstable angina despite optimal medical treatment, irrespective of the number of vessels involved. Operation should also be advised for patients with left main stem stenosis, and patients with triple coronary artery disease in whom stenoses are proximal. However, patients with poor left ventricular function (without resectable aneurysm), or with diffuse and/or distal disease with multiple stenoses, should be referred for operation only if symptoms are severe, accepting that results are likely to be less good in such patients. Such a policy presupposes an operative mortality of no more than 2-3% in patients with double or triple vessel disease and 1% in those with single vessel disease. In the early days of coronary bypass surgery and in less experienced centres, reported mortality rates of 5-6% were not uncommon, but with increasing experience and improved case-selection figures have generally improved .
. Aortocoronary bypass may be combined with other surgical procedures for complications of coronary artery disease, including left ventricular aneurysmectomy, closure of post-infarction ventricular septal defect, or mitral valve replacement for severe mitral regurgitation consequent upon papillary muscle infarction or rupture. Routine coronary arteriography in patients (particularly older patients, of both sexes) with severe aortic valve disease (with or without angina) or rheumatic mitral valve disease or nonrheumatic (but non-coronary) mitral regurgitation, reveals a proportion in whom severe coronary arterial stenosis may require bypassing at the time of operation for valve replacement (or repair).
Experience from a very large number of centres reporting results of aortocoronary bypass graft operations suggests that 7()-80% of all patients are free from angina after operation and that another 10% are improved. It has been shown in many studies that there is a close correlation between relief of symptoms and completeness of revascularization, and that the persistence of angina after operation results from early graft occlusion or incomplete revascularization. The importance of grafting all stenosed vesselswas not at first fully appreciated and surgeons early in their experience were sometimes reluctant to perform multiple grafts. On the other hand, some arteries are not graftable, either because they are too Small or because of the extent of distal disease, though this can sometimes be overcome by preliminary endarterectomy. Early graft patency is dependent on the size of the grafted vessel and the adequacy of run-off, which determine graft flow, as well as on technical factors; occlusion usually results from thrombosis of the graft. Perioperative infarction diagnosed by strict electrocardiographic criteria was reported to occur in 1()-15% of patients, but with increasing experience of surgeons the perioperative infarction rate has fallen to about 5%. There is no close correlation between the occurrence of perioperative infarction and clinical improvement.
Late recurrence of angina may be due to progression of native disease, either in grafted vessels distal to the site of graft insertion or in ungrafted vessels, or to late graft occlusion. It has been found that in the best hands about 90% of vein grafts are patent early after operation and that 80% are patent at one year. It is then relatively uncommon for grafts patent at one year to become occluded during the next 4 to 5 years, despite the almost invariable development of intimal fibrosis, leading to shortening and some reduction in luminal diameter of the graft. Late graft occlusion may be the result of thrombosis or of atherosclerotic changes which are commoner in hyperlipidaemic patients. Progression of stenosis or occlusion of grafted vessels commonly occurs proximal to the site of graft insertion, with the result that perfusion of the territory of the grafted vessel is dependent upon continued patency of the graft; while the graft remains patent proximal occlusion of the grafted artery may pass unnoticed. Increasing severity of distal disease is less common but may lead to the recurrence of angina; decreasing peripheral run-off by reducing graft flow may also be a cause of late occlusion of grafts. However, the commonest cause of late recurrence of angina is progressive disease in ungrafted, previously healthy or not critically stenosed, coronary arterial branches.
Many reoperations have been reported but the success rate is lower (about 50%) than for primary procedures. Relief of angina is more likely when persistence or recurrence of angina can be attributed to major stenosis of a previously ungrafted but graftable vessel (Brooks et al. 1979) . Regrafting of a previously grafted vessel or revision of an existing graft is less likely to be successful, because the factors leading to graft failure, unless this is attributable to faulty surgical technique, are still operating.
In conclusion, aortocoronary bypass grafting is an established surgical procedure of proven value in the relief of limiting angina unresponsive to optimal medical treatment. The effect of successful operation on long-term prognosis is still controversial, except when there is left main stem stenosis, though many cardiologists and surgeons believe that the evidence is now so strong that operation should be advised in many patients with proximal stenosis of two or three major coronary arteries even when symptoms are not pressing. Good results are related to continued graft patency; persisting angina after operation may be due to early graft occlusion or to the presence of ungrafted but stenosed vessels, but late recurrence of angina is as likely to be due to progression of native disease as to late graft occlusion, though this may occur as a result of the development of atherosclerotic changes in the vein graft. Reoperation is feasible in selected cases but less likely to be successful than primary operation.
